UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

The journal of clinical psychiatry, 2021-08, Vol.82 (5)

2021

Volltextzugriff (PDF)

A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials

Journal of attention disorders, 2024-06, Vol.28 (8), p.1186-1197

2024

Volltextzugriff (PDF)

4.56 Exploring Countertransference Through Film

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S222-S222

2018

Volltextzugriff (PDF)

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder

Neurology and therapy, 2024-08, Vol.13 (4), p.1081-1098

2024

Volltextzugriff (PDF)

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2017-08, Vol.27 (6), p.474-482

2017

Volltextzugriff (PDF)

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S170-S170

2016

Volltextzugriff (PDF)

2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S169-S169

2018

Volltextzugriff (PDF)

A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

Journal of attention disorders, 2014-02, Vol.18 (2), p.133-144

2014

Volltextzugriff (PDF)

5.21 EVALUATION OF THE EFFICACY AND SAFETY OF SHP465 MIXED AMPHETAMINE SALTS AT A LOW DOSE IN CHILDREN WITH ADHD: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY

Journal of the American Academy of Child and Adolescent Psychiatry, 2019-10, Vol.58 (10), p.S252-S252

2019

Volltextzugriff (PDF)

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2020-11, Vol.30 (9), p.549-557

2020

Volltextzugriff (PDF)

IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-10, Vol.60 (10), p.S257-S257

2021

Volltextzugriff (PDF)

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2007-07, Vol.46 (7), p.894-921

Pliszka, Steven, M.D

2007

Volltextzugriff (PDF)

Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study

CNS drugs, 2017-08, Vol.31 (8), p.685-697

2017

Volltextzugriff (PDF)

MANAGING PATIENT SCHEDULING USING BOTH TELEHEALTH VISITS AND IN PERSON VISITS IN CHILD AND ADOLESCENT PSYCHIATRY CLINIC

Journal of international management studies, 2022-03, Vol.22 (1), p.20-26

2022

Volltextzugriff (PDF)

A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2022-03, Vol.32 (2), p.98-106

2022

Volltextzugriff (PDF)

Efficacy and Safety of HLD200, a Novel Delayed-Release and Extended-Release Methylphenidate Formulation, in Children With Attention-Deficit/Hyperactivity Disorder: Results From a Pivotal Phase 3 Trial

Pediatrics (Evanston), 2018-05, Vol.142 (1_MeetingAbstract), p.794-794

2018

Volltextzugriff (PDF)

Effect of HLD200 on Caregiver-Reported ADHD Symptom Improvement in Children With ADHD and Caregiver Strain: Results from a Phase 3 Trial

Pediatrics (Evanston), 2018-05, Vol.142 (1_MeetingAbstract), p.810-810

2018

Volltextzugriff (PDF)

Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-09, Vol.48 (9), p.961-973

Walkup, John, M.D

2009

Volltextzugriff (PDF)

Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-02, Vol.41 (2), p.26S-49S

2002

Volltextzugriff (PDF)

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Substance Use Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-06, Vol.44 (6), p.609-621

Bukstein, Oscar G.

2005

Volltextzugriff (PDF)

Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal

Postgraduate medicine, 2015-04, Vol.127 (3), p.323-329

2015

Volltextzugriff (PDF)

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial

JAMA network open, 2023-04, Vol.6 (4), p.e239135

2023

Volltextzugriff (PDF)

130 Consistent Efficacy of DR/ER-MPH on Early Morning Functioning in Children With ADHD: Analysis of BSFQ Item Ratings From a Pivotal Phase 3 Trial

CNS spectrums, 2018-02, Vol.23 (1), p.82-82

2018

Volltextzugriff (PDF)

129 Effect of DR/ER-MPH on Caregiver-Reported ADHD Symptom Improvement in Children With ADHD and Caregiver Strain: Results From a Phase 3 Trial

CNS spectrums, 2018-02, Vol.23 (1), p.81-81

2018

Volltextzugriff (PDF)

128 Effect of DR/ER-MPH on Early Morning and Late Afternoon/Evening Functioning in Children With ADHD: Analysis of PREMB-R Items From a Phase 3 Trial

CNS spectrums, 2018-02, Vol.23 (1), p.80-81

2018

Volltextzugriff (PDF)

1 – 25 von 590

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(508)
Mit Volltextzugriff
(501)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(378)
Life Sciences & Biomedicine
(354)
Humans
(296)
Male
(192)
Female
(188)
Genetics & Heredity
(156)
Biological And Medical Sciences
(146)
Medical Sciences
(131)
Mutation
(98)
Child
(96)
Adult
(77)
Child, Preschool
(74)
Adolescent
(65)
Life Sciences
(65)
Medical Genetics
(61)
Pediatrics
(57)
Infant
(55)
Pedigree
(55)
Genetics
(51)
Fundamental And Applied Biological Sciences. Psychology
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials

4.56 Exploring Countertransference Through Film

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial

A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

5.21 EVALUATION OF THE EFFICACY AND SAFETY OF SHP465 MIXED AMPHETAMINE SALTS AT A LOW DOSE IN CHILDREN WITH ADHD: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder

IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study

MANAGING PATIENT SCHEDULING USING BOTH TELEHEALTH VISITS AND IN PERSON VISITS IN CHILD AND ADOLESCENT PSYCHIATRY CLINIC

A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder

Efficacy and Safety of HLD200, a Novel Delayed-Release and Extended-Release Methylphenidate Formulation, in Children With Attention-Deficit/Hyperactivity Disorder: Results From a Pivotal Phase 3 Trial

Effect of HLD200 on Caregiver-Reported ADHD Symptom Improvement in Children With ADHD and Caregiver Strain: Results from a Phase 3 Trial

Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents

Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Substance Use Disorders

Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal

Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial

130 Consistent Efficacy of DR/ER-MPH on Early Morning Functioning in Children With ADHD: Analysis of BSFQ Item Ratings From a Pivotal Phase 3 Trial

129 Effect of DR/ER-MPH on Caregiver-Reported ADHD Symptom Improvement in Children With ADHD and Caregiver Strain: Results From a Phase 3 Trial

128 Effect of DR/ER-MPH on Early Morning and Late Afternoon/Evening Functioning in Children With ADHD: Analysis of PREMB-R Items From a Phase 3 Trial

Suchergebnisse filtern